EUVIMEDEUVIMED entdecken
Open Access

Saline suppression testing-induced hypocalcemia and implications for clinical interpretations

Wasita W Parksook, Jenifer M Brown, Julia Milks, Laura C Tsai iD, Justin Chan, Anna Moore, Yvonne Niebuhr, Brooke Honzel, Andrew J Newman, Anand Vaidya iD

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Wasita W Parksook und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Adrenal Disorders, Boston, MA 02115, United States. Hauptthemen laut MEDLINE: Hypocalcemia, Calcium, Parathyroid Hormone, Hyperaldosteronism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH, American Heart Association-American Stroke Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extracellular calcium critically regulates physiologic aldosterone production. Moreover, abnormal calcium flux and signaling are involved in the pathogenesis of the majority of primary aldosteronism cases.

Methods

We investigated the influence of the saline suppression test (SST) on calcium homeostasis in prospectively recruited participants (n = 86).

Results

During SST, 100% of participants had decreases in serum calcium, with 48% developing frank hypocalcemia. Serum calcium declined from 2.30 ± 0.08 mmol/L to 2.13 ± 0.08 mmol/L (P < .001) with parallel increases in parathyroid hormone from 6.06 ± 2.39 pmol/L to 8.13 ± 2.42 pmol/L (P < .001). In contrast, serum potassium and bicarbonate did not change, whereas eGFR increased and serum glucose decreased (P < .001). Lower body surface area (translating to greater effective circulating volume expansion during SST) was associated with greater reductions in (β = .33, P = .001), and absolutely lower, serum calcium levels (β = .25, P = .001). When evaluating clinically-relevant diagnostic thresholds, participants with post-SST aldosterone levels <138 pmol/L had lower post-SST calcium and 25-hydroxyvitamin D levels (P < .05), and higher post-SST parathyroid hormone levels (P < .05) compared with those with post-SST aldosterone levels >277 pmol/L.

Conclusion

SST uniformly decreases serum calcium, which is likely to be due to the combination of variable dilution, increased renal clearance, and vitamin D status. These acute reductions in bioavailable calcium are associated with lower post-SST aldosterone. Given the critical role of extracellular calcium in regulating aldosterone production, these findings warrant renewed inquiry into the validity of SST interpretations for excluding primary aldosteronism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypocalcemiaCalciumParathyroid HormoneHyperaldosteronismHumansFemaleMaleMiddle AgedAdultAldosteroneSaline SolutionProspective StudiesAged

Stichwörter der Autor:innen

aldosteronecalciumhypocalcemiaparathyroid hormoneprimary aldosteronism

Substanzen

CalciumParathyroid HormoneAldosteroneSaline Solution

Autor:innen und Institutionen

  • Center for Adrenal Disorders, Boston, MA 02115, United States.
  • Division of Endocrinology, Diabetes, and Hypertension, Boston, MA 02115, United States.
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, United States.
  • Department of Medicine (Division of Endocrinology and Metabolism, and Division of General Internal Medicine), Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thai Red Cross Socie…
  • Division of Cardiovascular Medicine, Boston, MA 02115, United States.

ORCID-Profile: Laura C Tsai, Anand Vaidya

Förderung

  • NHLBI NIH HHS
  • NIH
  • American Heart Association-American Stroke Association
  • American Heart Association
  • NIDDK NIH HHS
  • NIH HHS
  • NHLBI
  • National Institutes of Health

Zitieren

APA

Parksook, W. W., Brown, J. M., Milks, J., Tsai, L. C., Chan, J., Moore, A., Niebuhr, Y., Honzel, B., Newman, A. J., & Vaidya, A. (2024). Saline suppression testing-induced hypocalcemia and implications for clinical interpretations. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae099

Vancouver

Parksook WW, Brown JM, Milks J, Tsai LC, Chan J, Moore A, et al. Saline suppression testing-induced hypocalcemia and implications for clinical interpretations. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae099

BibTeX
@article{Parksook2024,
  author = {Parksook, Wasita W and Brown, Jenifer M and Milks, Julia and Tsai, Laura C and Chan, Justin and Moore, Anna and Niebuhr, Yvonne and Honzel, Brooke and Newman, Andrew J and Vaidya, Anand},
  title = {Saline suppression testing-induced hypocalcemia and implications for clinical interpretations},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae099}
}
Kostenlos starten →